SP
ITCI

SIH Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

SIH Partners’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,685
Closed -$882K – 325
2025
Q1 		$882K Buy
+6,685
New +$833K 0.03% 127

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SIH Partners's ITCI Position: Q2 2025 in Review

SIH Partners sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 6,685 shares — an estimated $882K sold.

SIH Partners first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $882K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • SIH Partners reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • SIH Partners sold 6,685 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $882K.
  • SIH Partners first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
  • SIH Partners's Intra-Cellular Therapies Inc. position peaked at $882K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.